The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1β

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1863, Issue 3, 2017, Pages 712-720

  Farag, N S ^a   Breitinger, U ^a   El Azizi, M ^a   Breitinger, H G ^a  

^a German University in Cairo   (Egypt)

Author keywords

Hepatitis C; IL 1 ; Inflammasomes; Liver inflammation; NLPR3; P7 ion channel; Viroporins

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; ION CHANNEL; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; P7 PROTEIN; RIMANTADINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRAL PROTEIN; P7 PROTEIN, HEPATITIS C VIRUS; PROTON PUMP;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL PH; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; HEK293 CELL LINE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAW 264.7 CELL LINE; ANIMAL; COMPLICATION; HEPACIVIRUS; IMMUNOLOGY; INFLAMMATION; LIVER; VIROLOGY;

ANIMALS; HEK293 CELLS; HEPACIVIRUS; HEPATITIS C; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-1BETA; LIVER; MACROPHAGES; MICE; PROTON PUMPS; RAW 264.7 CELLS; VIRAL PROTEINS;

EID: 85007485824     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.12.006     Document Type: Article

References (44)

1. [1] Ali, A., Ahmed, H., Idrees, M., Molecular epidemiology of hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan. Virol. J., 7, 2010, 203.
2. [2] WHO, Hepatitis C Fact Sheet. http://www.who.int/mediacentre/factsheets/fs164/en/, July 2016.
3. [3] Shepard, C.W., Finelli, L., Alter, M.J., Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:9 (2005), 558–567.
4. [4] Suzuki, T., Aizaki, H., Murakami, K., Shoji, I., Wakita, T., Molecular biology of hepatitis C virus. J. Gastroenterol. 42:6 (2007), 411–423.
5. [5] Matsuura, Y., Harada, T., Makimura, M., Sato, M., Aizaki, M., Suzuki, H., Miyamura, T., Characterization of HCV structural proteins expressed in various animal cells. Intervirology 37:2 (1994), 114–118.
6. [6] Poynard, T., Ratziu, V., Benhamou, Y., Opolon, P., Cacoub, P., Bedossa, P., Natural history of HCV infection. Baillieres Best Pract. Res. Clin. Gastroenterol. 14:2 (2000), 211–228.
7. [7] Lauer, G.M., Walker, B.D., Hepatitis C virus infection. N. Engl. J. Med. 345:1 (2001), 41–52.
8. [8] Griffin, S.D., Harvey, R., Clarke, D.S., Barclay, W.S., Harris, M., Rowlands, D.J., A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J. Gen. Virol. 85:2 (2004), 451–461.
9. [9] Premkumar, A., Wilson, L., Ewart, G.D., Gage, P.W., Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett. 557:1 (2004), 99–103.
10. [10] Breitinger, U., Farag, N., Ali, N.K., Breitinger, H.G., Patch-clamp study of hepatitis C p7 channels reveals genotype-specific sensitivity to inhibitors. Biophys. J. 110:11 (2016), 2419–2429.
11. [11] Carrere-Kremer, S., Montpellier-Pala, C., Cocquerel, L., Wychowski, C., Penin, F., Dubuisson, J., Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J. Virol. 76:8 (2002), 3720–3730.
12. [12] Griffin, S.D., StGelais, C., Owsianka, A.M., Patel, A.H., Rowlands, D., Harris, M., Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology 48:6 (2008), 1779–1790.
13. [13] Wozniak, A.L., Griffin, S.D., Rowlands, D., Harris, M., Yi, M.K., Lemon, S.M., Weinman, S.A., Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production. PLoS Pathog., 6(9), 2010, e1001087.
14. [14] Liang, T.J., Ghany, M.G., Current and future therapies for hepatitis C virus infection. N. Engl. J. Med. 368:20 (2013), 1907–1917.
15. [15] Belouzard, S., Cocquerel, L., Dubuisson, J., Hepatitis C virus entry into the hepatocyte. Cent. Eur. J. Biol. 6:6 (2011), 933–945.
16. [16] Schroder, K.T., Tschopp, J., The inflammasomes. Cell 140:6 (2010), 821–832.
17. [17] Tschopp, J., Martinon, F., Burns, K., NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4 (2003), 95–104.
18. [18] Breitinger, U., Breitinger, H.G., Bauer, F., Fahmy, K., Glockenhammer, D., Becker, C.M., Conserved high affinity ligand binding and membrane association in the native and refolded extracellular domain of the human glycine receptor alpha1-subunit. J. Biol. Chem. 279 (2004), 1627–1636.
19. [19] Gonzalez, M.E., Carrasco, L., Viroporins. FEBS Lett. 552:1 (2003), 28–34.
20. [20] Brohm, C.S., Friesland, E., Lorenz, M., Patel, I.C., Penin, A.F., Bartenschlager, R., Pietschmann, T., Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation. J. Virol. 83:22 (2009), 11682–11693.
21. [21] Sakai, A., Claire, M.S., Faulk, K., Govindarajan, S., Emerson, S.U., Purcell, R.H., Bukh, J., The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc. Natl. Acad. Sci. U. S. A. 100:20 (2003), 11646–11651.
22. [22] Steinmann, E., Pietschmann, T., Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy. Viruses 2:9 (2010), 2078–2095.
23. [23] Griffin, S.D., Beales, L.P., Clarke, D.S., Worsfold, O., Evans, S.D., Jaeger, J., Harris, M.P., Rowlands, D.J., The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine. FEBS Lett. 535:1–3 (2003), 34–38.
24. [24] Pavlovic, D., Neville, D.C.A., Argaud, O., Blumberg, B., Dwek, R.A., Fischer, W.B., Zitzmann, N., The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 6104–6108 (0027–8424 (Print)).
25. [25] Capellini, V.K., Restini, C.B.A., Bendhack, L.M., Evora, P.R.B., Celotto, A.C., The effect of extracellular pH changes on intracellular pH and nitric oxide concentration in endothelial and smooth muscle cells from rat aorta. PLoS One, 8(5), 2013, e62887.
26. [26] Smith, G.L., Austin, C., Crichton, C., Wray, S., A review of the actions and control of intracellular pH in vascular smooth muscle. Cardiovasc. Res. 38 (1998), 316–331.
27. [27] Wray, S., Smooth muscle intracellular pH: measurement, regulation, and function. Am. J. Phys. 254 (1988), C213–C225.
28. [28] Ludwig, M.G., Vanek, M., Guerini, D., Gasser, J.A., Jones, C.E., Junker, U., Hofstetter, H., Wolf, R.M., Seuwen, K., Proton-sensing G-protein-coupled receptors. Nature 425:6953 (2003), 93–98.
29. [29] Li, K., Chen, Z., Kato, N., Gale, M. Jr., Lemon, S.M., Distinct poly(I-C) and virus activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280 (2005), 16739–16747.
30. [30] Gong, G., Waris, G., Tanveer, R., Siddiqui, A., Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kB. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9599–9604.
31. [31] Moschen, A.R., Fritz, T., Clouston, A.D., Rebhan, I., Bauhofer, O., Barrie, H.D., Powell, E.E., Kim, S.H., Dinarello, C.A., Bartenschlager, R., Jonsson, J.R., Tilg, H., IL 32: a new proinflammatory cytokine involved in HCV-related liver inflammation and fibrosis. Hepatology 53 (2011), 1819–1829.
32. [32] Dinarello, C.A., Interleukin-1 and the pathogenesis of the acute-phase response. N. Engl. J. Med. 311 (1984), 1413–1418.
33. [33] Lapinski, T.W., The levels of IL-1 β, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients. Ther. Exp. (Warsz) 49 (2001), 311–316.
34. [34] Martinon, F., Tschopp, J., Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004), 561–574.
35. [35] Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229–265.
36. [36] Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., Latz, E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9 (2008), 847–856.
37. [37] Burdette, D., Haskett, A., Presser, L., McRae, S., Iqbal, J., Waris, G., Hepatitis C virus activates interleukin-1beta via caspase-1-inflammasome complex. J. Gen. Virol. 93:Pt2 (2012), 235–246.
38. [38] Takahashi, K., Asabe, S., Wieland, S., Garaigorta, U., Gastaminza, P., Isogawa, M., Chisari, F.V., Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 7431–7436.
39. [39] Negash, A.A., Ramos, H.J., Crochet, N., Lau, D.T., Doehle, B., Papic, N., Delker, D.A., Jo, J., Bertoletti, A., Hagedorn, C.H., Gale, M. Jr., IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog., 9(4), 2013, e1003330.
40. [40] Ichinohe, T., Pang, I.K., Iwasaki, A., Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 11:5 (2010), 404–410.
41. [41] Pang, I.K., Iwasaki, A., Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 32:1 (2011), 34–41.
42. [42] Ito, M., Yanagi, Y., Ichinohe, T., Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog., 8(8), 2012.
43. [43] Wang, K., Viroporin activates inflammasome. J. Appl. Virol. 2:1 (2013), 1–5.
44. [44] Nelson, D.R., Lim, H.L., Marousis, C.G., Fang, J.W., Davis, G.L., Shen, L., Urdea, M.S., Kolberg, J.A., Lau, J.Y., Activation of tumor necrosis factor-a system in chronic hepatitis C virus infection. Dig. Dis. Sci. 42 (1997), 2487–2494.